Series C - Axial Biotherapeutics
Investment Firm
Overview
Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.
Announced Date
Oct 13, 2021
Funding Type
Series C
Highlights
Location
United States, North America
Social
Participant Investors
7
Round Details and Background
Axial Biotherapeutics raised $37250000 on 2021-10-13 in Series C
Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 20, 2019 |  Series B - Axial Biotherapeutics | 1 | - | 10.0M |
| Dec 01, 2016 | Series A - Axial Biotherapeutics | 3 | - | 19.1M |
| Oct 13, 2021 | Series C - Axial Biotherapeutics | 8 | - | 37.3M |
| Nov 30, 2016 | Series A - Axial Biotherapeutics | 4 | - | 19.5M |
Recent Activity
There is no recent news or activity for this profile.